Abstract
This research note provides valuable insights into the significance of prediabetes and its potential links to type 2 diabetes, heart disease, and stroke. Emphasizing early detection and intervention, it challenges common perceptions by presenting prediabetes as a reversible metabolic disorder. The connections between lower albumin levels, impaired GLP-1 response, and prediabetes suggest promising avenues for early diabetes prevention through incretin-based therapies. The call for further research highlights the ongoing need to assess the effectiveness of such interventions and deepen our understanding of the interplay between GLP-1, albumin, and prediabetes.